Calcium di(benzenesulphonate) | 934-54-3

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物 - 环羧酸
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: Calcium di(benzenesulphonate)
• 英文别名: calcium;benzenesulfonate
• CAS: 934-54-3
• 化学式: C12H10CaO6S2
• 分子量: 354.4
• InChiKey: VJOCYCQXNTWNGC-UHFFFAOYSA-L

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  21
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  131
• 氢给体数：
  0
• 氢受体数：
  6

安全信息

• 海关编码：
  2904100000

文献信息

• [EN] NOVEL R,R'-ATRACURIUM SALTS<br/>[FR] NOUVEAUX SELS DE R,R'-ATRACURIUM
  申请人：CHEMAGIS LTD

  公开号：WO2009057086A1

  公开（公告）日：2009-05-07

  The present invention provides R,R'-atracurium salts, processes for producing and purifying such salts, and methods of using such salts to produce highly pure cisatracurium besylate.

  本发明提供了R，R'-阿曲库铵盐，生产和纯化这种盐的方法，以及使用这种盐生产高纯度顺阿曲库铵苄甲酸盐的方法。
• SOLID STATE FORMS OF DEFERASIROX SALTS AND PROCESS FOR THE PREPARATION THEREOF
  申请人：Neela Praveen Kumar

  公开号：US20110097413A1

  公开（公告）日：2011-04-28

  Provided herein are novel solid state forms of deferasirox salts, process for the preparation, pharmaceutical compositions, and method of treating thereof. The solid state forms of deferasirox salts are useful for preparing deferasirox (I) in high purity.

  本文提供了新型固态形式的去铁医药盐，其制备方法，制药组合物以及治疗方法。这些去铁医药盐的固态形式有助于高纯度地制备去铁医药(I)。
• Amorphous Coprecipitates of Atorvastatin Pharmaceutically Acceptable Salts
  申请人：Dixit Girish

  公开号：US20110142883A1

  公开（公告）日：2011-06-16

  The present invention relates to stable amorphous co-precipitates of atorvastatin pharmaceutically acceptable salts with pharmaceutically acceptable excipients, method for the preparation, pharmaceutical compositions, and method of treating thereof. Advantageously, the amorphous co-precipitates of atorvastatin pharmaceutically acceptable salts of the present invention have improved physiochemical characteristics that assist in the effective bioavailability

  本发明涉及阿托伐他汀药物可接受盐与药物可接受辅料的稳定非晶共沉淀物、制备方法、制药组合物及其治疗方法。有益的是，本发明的阿托伐他汀药物可接受盐的非晶共沉淀物具有改善的物理化学特性，有助于有效的生物利用度。
• Novel Polymorph of Atorvastatin Calcium and Use Thereof for the Preparation of Amorphous Atorvastatin Calcium
  申请人：Dixit Girish

  公开号：US20100260851A1

  公开（公告）日：2010-10-14

  The present invention provides a novel polymorphic form of atorvastatin calcium, designated as form Al, process for preparation, pharmaceutical compositions, and method of treating thereof. The present invention further provides a process for the preparation of highly pure amorphous atorvastatin calcium using the novel atorvastatin calcium form Al. The present invention also relates to novel amorphous form of atorvastatin tert-butyl ester, chemically known as [R-(R*,R*)]-2-(4-fluorophenyl)-[β],[δ]-dihydroxy -5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl-1H-pyrrole-1-heptanoicacid tert-butyl ester, process for the preparation, and its application for preparing highly pure atorvastatin and its pharmaceutically acceptable salts thereof. The present invention also relates to use of the novel amorphous atorvastatin tert-butyl ester and novel atorvastatin calcium form al for preparing amorphous atorvastatin calcium.

  本发明提供了阿托伐他汀钙的一种新的多晶形式，称为Al型，制备方法、制药组合物和治疗方法。本发明还提供了一种使用新的阿托伐他汀钙Al型制备高纯非晶态阿托伐他汀钙的方法。本发明还涉及阿托伐他汀叔丁基酯的新非晶态形式，化学名称为[R-(R*，R*)]-2-(4-氟苯基)-[β]，[δ]-二羟基-5-(1-甲基乙基)-3-苯基-4-(苯基羰氨基)-1H-吡咯烷-1-庚酸叔丁基酯，制备方法及其应用于制备高纯阿托伐他汀及其药用盐。本发明还涉及使用新的非晶态阿托伐他汀叔丁基酯和新的阿托伐他汀钙Al型制备非晶态阿托伐他汀钙。
• [EN] AQUEOUS CAPSULE SUSPENSION CONCENTRATES BASED ON POLYUREA SHELL MATERIAL CONTAINING POLYFUNCTIONAL AMINOCARBOXYLIC ESTERS<br/>[FR] CONCENTRÉS DE SUSPENSION DE CAPSULE AQUEUSE À BASE DE MATÉRIAU D'ENVELOPPE DE POLYURÉE CONTENANT DES ESTERS AMINOCARBOXYLIQUES POLYFONCTIONNELS
  申请人：BAYER AG

  公开号：WO2021136758A1

  公开（公告）日：2021-07-08

  The present invention relates to aqueous capsule suspension concentrates based on polyurea shell material containing polyfunctional aminocarboxylic esters, the production thereof and the use thereof as an agrochemical formulation that provide better biodegradability.

  本发明涉及基于聚氨酯壳材料的多功能氨基羧酸酯的水胶囊悬浮浓缩物，其制备方法以及作为农药配方的使用，提供更好的生物降解性。